Comparison between the therapeutic effects of differentiated and undifferentiated Wharton's jelly mesenchymal stem cells in rats with streptozotocin-induced diabetes

Figure 1 Morphology of undifferentiated human Wharton's jelly mesenchymal stem cells and islet-like clusters differentiated from human Wharton's jelly mesenchymal stem cells. A: Undifferentiated spindle-shaped human Wharton's jelly mesenchymal stem cells (20 ×); B: Islet-like clusters after differentiation (20 ×); C: Dithizone-positive cells, which represent insulin-secreting cells (20 ×); D-G: Immunofluorescence staining with anti-insulin antibodies (green) and anti-human-nuclei antibodies (red) (40 ×).